Emergent BioSolutions Inc.
EBS
$9.12
-$0.115-1.25%
NYSE
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 267.30M | 149.10M | 99.50M | 149.90M | 69.70M |
| Total Receivables | 79.80M | 203.70M | 154.50M | 121.30M | 196.30M |
| Inventory | 338.60M | 314.00M | 311.70M | 322.70M | 317.50M |
| Prepaid Expenses | 24.00M | 30.20M | 26.90M | 61.00M | 36.00M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 9.80M | 9.80M | 6.10M | 6.50M | 35.00M |
| Total Current Assets | 719.50M | 706.80M | 598.70M | 661.40M | 654.50M |
|
|
|||||
| Total Current Assets | 719.50M | 706.80M | 598.70M | 661.40M | 654.50M |
| Net Property, Plant & Equipment | 223.80M | 227.60M | 282.30M | 290.50M | 319.90M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 469.00M | 485.20M | 501.50M | 517.80M | 534.10M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 4.80M | 6.50M | 7.20M | 8.10M | 5.00M |
| Total Assets | 1.42B | 1.43B | 1.39B | 1.48B | 1.51B |
|
|
|||||
| Total Accounts Payable | 63.70M | 58.10M | 60.90M | 82.10M | 95.90M |
| Total Accrued Expenses | 45.10M | 37.90M | 73.80M | 79.40M | 83.90M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.80M | 1.90M | 2.70M | 3.50M | 418.30M |
| Total Finance Division Other Current Liabilities | 16.50M | 14.00M | 25.00M | 64.90M | 21.60M |
| Total Other Current Liabilities | 16.50M | 14.00M | 25.00M | 64.90M | 21.60M |
| Total Current Liabilities | 127.10M | 111.90M | 162.40M | 229.90M | 619.70M |
|
|
|||||
| Total Current Liabilities | 127.10M | 111.90M | 162.40M | 229.90M | 619.70M |
| Long-Term Debt | 667.80M | 665.70M | 663.70M | 661.80M | 447.00M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 6.50M | 5.10M | 9.70M | 10.70M | 11.50M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 79.50M | 90.70M | 71.10M | 67.00M | 49.00M |
| Total Liabilities | 880.90M | 873.40M | 906.90M | 969.40M | 1.13B |
|
|
|||||
| Common Stock & APIC | 935.30M | 930.90M | 928.10M | 924.50M | 915.40M |
| Retained Earnings | -156.40M | -144.40M | -212.40M | -181.10M | -295.90M |
| Treasury Stock & Other | -242.70M | -233.80M | -232.90M | -235.00M | -233.20M |
| Total Common Equity | 536.20M | 552.70M | 482.80M | 508.40M | 386.30M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 536.20M | 552.70M | 482.80M | 508.40M | 386.30M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 536.20M | 552.70M | 482.80M | 508.40M | 386.30M |
|
|
|||||